Methoxyphenamine O-demethylase and 5-hydroxylase: A GLC-ECD assay to study their activities and their inhibition by debrisoquine and sparteine

This publication has 15 references indexed in Scilit:

• Metabolism of methoxyphenamine in extensive and poor metabolizers of debrisoquin
  Clinical Pharmacology & Therapeutics, 1985
• Methoxyphenamine metabolism in rat models of human debrisoquine phenotypes
  Canadian Journal of Physiology and Pharmacology, 1985
• Phenotypic consistency in hydroxylation of desmethylimipramine and debrisoquine in healthy subjects and in human liver microsomes
  Clinical Pharmacology & Therapeutics, 1984
• A radiometric assay for debrisoquine 4-hydroxylase in human liver microsomes
  Canadian Journal of Physiology and Pharmacology, 1984
• Molecular aspects of debrisoquine metabolism studied by gas chromatography mass spectrometry with electron capture negative ion chemical ionisation
  International Journal of Mass Spectrometry and Ion Physics, 1983
• Identification of new secondary metabolites of methoxyphenamine in man
  Xenobiotica, 1983
• Assay and characterisation of debrisoquine 4‐hydroxylase activity of microsomal fractions of human liver.
  British Journal of Clinical Pharmacology, 1982
• Animal modelling of human polymorphic drug oxidation—the metabolism of debrisoquine and phenacetin in rat inbred strains
  Journal of Pharmacy and Pharmacology, 1981
• Defective N-oxidation of sparteine in man: A new pharmacogenetic defect
  European Journal of Clinical Pharmacology, 1979
• POLYMORPHIC HYDROXYLATION OF DEBRISOQUINE IN MAN
  The Lancet, 1977